Studies related to HDL-C and Royal Jelly

Effects Of An Herbal Medication Containing Bee Products On Menopausal Symptoms And Cardiovascular Risk Markers: Results Of A Pilot Open-uncontrolled Trial

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 55
Gender Female
Age Range 45-64
Notes for this study:
The usage of Melbrosia (royal jelly, pollen, perga-pollen) in post-menopausal women was able to decrease various symptoms of menopause as assessed by Kupperman score (survey) when supplemented at 2 caps daily for 2 weeks, then 1 cap daily for 10 week, for 12 weeks.

C-Reactive protein and VCAM-1 were not significantly affected.

Royal Jelly Supplementation Improves Lipoprotein Metabolism In Humans

Effect None
Trial Design Cohort
Trial Length 2-4 Weeks
Number of Subjects 15
Gender Both Genders
Age Range 30-44
Body Types Average
Notes for this study:
6g of Royal Jelly daily for 4 weeks was able to reduce LDL without significantly affecting HDL or TGs in persons of both sexes aged 39+/-9.9 years of age.

Effect Of Royal Jelly Ingestion For Six Months On Healthy Volunteers

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 56
Gender Both Genders
Age Range 45-64, 65+
Body Types Overweight, Average
Notes for this study:
3000mg Royal Jelly for 6 months was able to slightly benefit testosterone levels in otherwise healthy adults, but failed to improve cardiovascular parameters and only benefitted blood glucose rather than other markers of glucose metabolism.